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Gregory L. Moneta, MD, Section EditorAge-Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary
Embolism: The ADJUST-PE Study
Righini M, Van Es J, Den Exter PL, et al. JAMA 2014;311:1117-24.
Conclusions: Compared with a ﬁxed D-dimer cutoff 500 mg/L, a
combination of pretest clinical probability assessment with age-adjusted
D-dimer cutoff is associated with a large number of patients in whom PE
can be considered ruled out with a low likelihood of subsequent clinical
venous thromboembolism (VTE).
Summary: In patients with currently suspected acute pulmonary em-
bolism (PE) sequential diagnostic tests, such as clinical probability assess-
ment, plasma D-dimer measurement, compression ultrasound, computed
tomography pulmonary angiography (CTPA), or ventilation-perfusion lung
scanning is used as a standard diagnostic approach. D-dimer testing has
also been evaluated extensively for the exclusion of PE particularly in outpa-
tients (Righini M et al, J Thromb Haemost 2008;6:1059-71). However,
D-dimer levels normally increase with age. Therefore the clinical usefulness
of the test may be limited in older patients. Previously it was found that
D-dimer testing was able to rule out PE in 60% of patients younger than
40 years, but only 5% of patients older than 80 years (Righini M, et al. J
ThrombHaemost 2007;5:1869-77). The authors here have previously retro-
spectively determined a progressive D-dimer cutoff adjusted for age in a sam-
ple of 1712 patients. They deﬁned optimal age-adjusted cutoff as the patients
age multiplied by 10 in patients 50 years or older (Douma RA et al, BMJ
2010;340:c1475). To conﬁrm the utility of this cutoff a multicenter, multi-
national, prospective management outcome study was conducted in 19 cen-
ters in Belgium, France, The Netherlands, and Switzerland between January
1, 2010 and February 28, 2013. Consecutive patients who presented to the
emergency department with clinical suspected PE were assessed by a sequen-
tial diagnostic strategy based on the clinical probability assessmeny with the
revised Geneva score or the 2-level Wells score for PE; high sensitive D-dimer
measurement; and CTPA. Patients with D-dimer values between the conven-
tional cutoff of 500 mg/L and their age-adjusted cutoff did not undergo
CTPA and were left untreated and followed for 3 months. Primary outcome
was the failure rate of the diagnostic strategy, deﬁned as the rate of adjudi-
cated VTE events during the 3 month follow-up period among patients
not treated with anticoagulants on the basis of a negative age-adjusted
D-dimer cutoff result. Of the 3346 patients with suspected PE included in
the study, the prevalence of PE was 19%. Among the 2898 patients with a
nonhigh or an unlikely clinical probability of PE, 817 patients (28.2%) had
a D-dimer level lower than 500 mg/L (95% CI, 26.6%-29.9%), and 337 pa-
tients (11.6%) had a D-dimer between 500 mg/L and their age-adjusted cut-
off (95% CI, 10.5%-12.9%). The 3-month failure rate in patients with a
D-dimer level higher than 500 mg/L but below the age-adjusted cut-off
was 1 of 331 patients (0.3%; 95% CI, 0.1%-1.7%). Among 776 patients 75
years or older, there were who 673 had a non-high clinical probability, using
the age-adjusted cutoff instead of the 500 mg/L cut-off. This increased the
proportion of patients in whomPE could be excluded on the basis of D-dimer
from 43 of 673 patients (6.4%; 95% CI, 4.8%-8.5%) to 200 of 673 patients
(29.7%; 95% CI, 26.4%-33.3%), with no additional false-negative ﬁndings.
Comment: It is important to remember that the ﬁndings for D-dimer
for exclusion of PE, as presented in this study, still applies only to outpatients.
However, it does appear that the use of age-adjusted D-dimer cutoffs in clin-
ical practice for evaluation of PE in outpatients has potential for improved
cost effectiveness and improved quality of care, particularly in older patients.
Additional studies to address these particular issues will be required before
wide-spread adoption of age-adjusted D-dimer cutoffs can be expected.
Progression Rate and Ipsilateral Neurological Events in Asymptomatic
Carotid Stenosis
Hirt LS Stroke 2014;45:702-6.
Conclusions: Rapid rates of progression of carotid artery stenosis
portend signiﬁcantly increased risk of future ipsilateral neurologic events.
Summary: About 3.6% of the general population has a $50% asymp-
tomatic carotid artery stenosis with attendant increased risk of future stroke.
Given that recent evidence suggests stroke risk is fallowing with carotid ste-
nosis identifying those lesions with a particular high risk of stroke would be
important. Potential risk factors for stroke with carotid artery stenosis includethe degree of carotid narrowing, plaque morphology, plaque hemorrhage,
detection of cerebral microemboli, and progression rates of luminal narrow-
ing. Stenosis progression occurrs in 5% to 20% of patients with asymptomatic
carotid stenosis (Norris JW et al, Stroke 1992;23:483-5, and Lewis RF et al,
Ann Intern Med 1997;127:13-20). In this study the authors sought to eval-
uate the yearly rate of change of carotid luminal narrowing as a risk factor for
ipsilateral ischemic neurologic events in patients with $50% asymptomatic
carotid stenosis. Patients were those who took part in the deferred endarter-
ectomy arm of the Asymptomatic Carotid Surgery Trial (ACST). Secondary
aims were to establish the annual incidence of progression and regression of
luminal narrowing and identify other risk factors associated with ipsilateral
neurological events in these patients. This was a retrospective analysis of
data derived from the deferred endarterectomy arm of the Asymptomatic
Carotid Surgery Trial. Patients were followed for $5years with serial carotid
duplex examinations. Data were derived from information obtained at
randomization and annual follow-up visits with carotid duplex studies. Po-
tential risk factors for ipsilateral neurological events were analyzed in Pois-
son regression models. There were data from 1469 patients included. 244
had ipsilateral events; 240 had ipsilateral carotid surgery; 370 died from
nonstroke causes and 82 had an asymptomatic carotid occlusion. The
annual incidence of contralateral symptoms showed a signiﬁcant indepen-
dent association with ipsilateral neurological events. Ipsilateral events
were associated with higher rates of progression over 1 year but not with
low progression rates.
Comment: The results of this study have signiﬁcant implications for
clinical practice. Duplex measurements demonstrating a slow rate of pro-
gression of asymptomatic carotid stenosis should not be interpreted as a
sign of increase risk of future neurologic events. Faster rates of progression
are associated with an increased risk of future ipsilateral neurologic events
and perhaps therefore can be used as one of the variables in the decision
to perform intervention for asymptomatic carotid stenosis.
Clinical and Cost-Effectiveness of Compression Hosiery Versus
Compression Bandages in Treatment of Venous Leg Ulcers (Venous
leg Ulcer Study IV, VenUS IV): A Randomised Controlled Trial
Ashby R, Gabe R, Ali S, et al. Lancet 2014;383:871-9.
Conclusions: Two-layer compression hosiery and four-layer bandages
are equally effective in healing venous leg ulcers.
Summary: Four-layer multi-component compression bandages are
regarded by many as the gold standard compression system to treat
venous leg ulceration (O’Meara S et al, Cochrane Database Syst Rev
2012;(1):CD000265). Two-layer compression hosiery systems have also
been marketed for treatment of venous leg ulcers. They are designed to
deliver 40 mm Hg of compression at the ankle when both layers under-
stocking and overstocking are worn together. Two-layer hosiery is less bulky
than a four-layer bandage and can be more easily worn with shoes and might
enhance ankle or leg mobility and therefore patient adherence. There is
however, little evidence from randomized controlled trials of the effective-
ness of two-layer hosiery for ulcer healing. There have been no trials
comparing two-layer hosiery and four-layer bandages. In this study the au-
thors sought to compare the clinical effectiveness and cost effectiveness of
two-layer hosiery with four-layer bandages for healing of venous ulcers.
This was an open randomized control trial with two parallel groups con-
ducted in 34 centers in England and Northern Ireland. Centers were com-
munity nurse teams or services, family doctor practices, leg ulcer clinics,
tissue viability clinics or services, and wound clinics. Study participants
were 18 years of age or older with a venous leg ulcer and an ankle brachial
pressure index of at least 0.8, and were able to tolerate high compression.
Participants were manually allocated 1:1 to receive two-layer compression
hosiery or a four-layer bandage using a remote randomization service and
a prevalidated computer randomization program. Stratiﬁcation was by ulcer
duration and ulcer area with permuted blocks. The primary end point was
time to ulcer healing with a maximum follow-up of 12 months. Participants
and health-care providers were not masked to treatment allocation but the
primary end point was measured by masked assessment of photographs. Pri-
mary analysis was intention to treat with Cox regression, with adjustment
for ulcer area, ulcer duration, physical mobility and center. Secondary end
points were unmasked outcome assessment, unmasked measurement of1469
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use, treatment change, adverse events, and ulcer recurrence. Health-related
quality of life and resource use were measured at baseline and every 3
months thereafter by participant self-completion of the SF-12 and
EQ-5D. Adverse events were classiﬁed as serious (death, life-threatening,
or limb-threatening) or non-serious. After the reference leg ulcer healed
nurses assessed ulcer recurrence on a monthly basis. There were 457 partic-
ipants in the two treatment groups: 230 in the two-layer group and 227 in
the four-layer bandage group. Of these, 230 in the hosiery and 223 in the
bandage group contributed data for analysis. Median time to ulcer healing
was 99 days (95% CI, 84-126) in the hosiery group and 98 days (95% CI,
85-112) in the bandage group. The proportion of ulcer healing was the
same in the two groups (70.9% hosiery and 70.4% bandage). There was
no evidence of a difference in the mental component summary score by
treatment over 12 months. Patients allocated to hosiery had a higher phys-
ical component summary score than those assigned to four-layer bandages,
suggesting better physical health in the hosiery group. This was after adjust-
ment for ulcer area, ulcer duration, participant mobility, center and time.
One hundred ﬁfty of the 454 (33%) participants changed to a non-trial
treatment before their ulcers healed, and more did so in the hosiery group
(38%) than in the bandage group (28%; P ¼ .02). Adverse event frequency
was similar in both groups except that in the hosiery group there were more
non-serious adverse events (67% vs 58%) than in the bandage group. In
follow-up, 14% of the patients in the hosiery group had ulcer recurrence
compared with 23% of patients in the bandage group: hazard ratio, 0.56;
95% CI, 0.33-0.94; P ¼ .026. Mean average costs were £300 lower per
participant in the hosiery group than in the bandage group with the differ-
ence ascribed to more frequent nurse consultations in the bandage group.
Comment: The data indicate that the two forms of compression
tested are both quite effective in the healing of venous leg ulcers. The higher
rate of treatment changes in the participants of the hosiery group suggests
that hosiery may not be suitable for all patients with venous leg ulcers.
Treatment modality is likely best individualized based on potential patient
compliance and center expertise.
Compression Stockings to Prevent Post-Thrombotic Ayndrome: A
Randomised Placebo-Controlled Trial
Kahn SR, Shapiro S, Wells PS, et al. Lancet 2014;383:880-8.
Conclusions: Elastic compression stockings do not prevent post-
thrombotic syndrome (PTS) after a ﬁrst proximal deep venous thrombosis
(DVT).
Summary: Two previous single center randomized trials have sug-
gested that wearing elastic compression stockings for 2 years after proximal
DVT can halve the risk of developing PTS. The trials, however, were small
and not placebo controlled. It is obvious that stockings can be cumbersome
to apply, can be hot and uncomfortable, and can itch in many patients. In
addition, they can be expensive, up to $100 or more per pair, and need to
be replaced twice yearly because of wear and tear, and frequently are not
covered by health care plans. PTS reduces quality of life and poses a substan-
tial economic burden on patients and society. Therefore any technique to
prevent post-thrombotic syndrome in patients with DVTwould be welcome.
The authors conducted a multicenter randomized placebo-controlled trial of
active versus placebo elastic compression stockings used for 2 years in an
effort to prevent PTS after a ﬁrst proximal DVT. Patients with an ultrasound
conﬁrmed ﬁrst proximal DVTwere randomly assigned to study groups with a
web based randomization system. Any patient with a ﬁrst symptomatic prox-
imal DVT was eligible for the study. The patients were excluded if the use of
compression stockings was contraindicated or they had an expected life ex-
pectancy of less than 6 months or geographic inaccessibility that precluded
return for follow-up visits or if they were unable to apply stockings or they
had received thrombolytic therapy as part of their initial treatment of acute
DVT. The primary outcome was PTS diagnosed at 6 months or later using
Ginsberg’s criteria (leg pain and swelling of$1 month duration). Secondary
outcomes included cumulative incidence and severity of PTS with Villalta’s
score, objectively conﬁrmed recurrent venous thromboembolism, death,
adverse events, venous valvular reﬂux, and quality of life. The authors used
a modiﬁed intention to treat Cox regression analysis, supplemented by pre-
speciﬁed per-protocol analysis of patients who reported frequent use of their
allocated treatment. The active stockings were 30-40 mm Hg stockings
whereas the placebo stockings provided only 5 mm Hg of compression at
the level of the ankle. The stocking appeared similar and patients were asked
not to wear their stockings to their follow-up visits which occurred at 1, 6, 12,
18, and 24 months. From 2004 to 2010, 410 patients were randomly
assigned to receive active elastic compression stockings and 396 placebo
elastic compression stockings. The cumulative incidence of PTS was 14.2%
in the active ECS versus 12.7% in the placebos ECS group (hazard ratio
adjusted for center, 1.13; 95% CI, 0.73-1.76; P ¼ .58). Results were similar
in the prespeciﬁed per-protocol analysis of patients who reported frequent useof stockings. In addition the 2 year cumulative incidence of Villalta-deﬁned
PTS in both the active and placebo stocking groups in this study were similar
to the control arms of previous trials that had reported beneﬁt of stockings
(Brandjes DPM et al, Lancet 1997;349:759-62, and Prandoni P et al, Ann
Intern Med 2004;141:249-56).
Comment: Results of this trial do not support the routine use of
elastic compression stockings after proximal DVT to prevent PTS. Howev-
er, while the results suggest that elastic compression stockings might not
affect the natural history of PTS development after DVT, whether compres-
sion stockings might be of beneﬁt to improve symptoms of established PTS
or of acute DVT remain open questions.
Endovascular or Open Repair Strategy for Ruptured Abdominal Aortic
Aneurysm: Thirty-Day Outcomes from IMPROVE Randomised Trial
IMPROVE trial investigators, Powell JT, Sweeting MJ, et al. BMJ
2014;348:f7661.
Conclusions: In patients with ruptured abdominal aortic aneurysm
(rAAA) a strategy of endovascular repair is not associated with signiﬁcant
reduction in 30- day mortality or cost.
Summary: Endovascular repair for rAAA has emerged as a treatment
strategy for anatomically suitable patients with rAAA. This has been on the
basis of observational studies which have suggested that repair of rAAA
with EVAR may be associated with lower perioperative mortality than repair
of rAAA with open techniques. However, observational studies do not
consider individual center expertise and this potentially inﬂuences selection
of patients and diagnostic criteria. A recent trial from The Netherlands found
no difference in 30-day mortality between EVAR and open repair groups
withmortality rates of 21% and 25% respectively in theDutch trial (Reimerink
JJ et al, Ann Surg 2013; 258:248-56). However, in the Dutch trial only pa-
tients anatomically suitable for endovascular repair were randomized to either
endovascular or open repair. Investigators in the IMPROVE trial felt their
method of randomization was more of a real world scenario. In IMPROVE,
patients were randomized either to an endovascular strategy (immediate CT
scan followed by EVAR if locally determined as anatomically suitable for
EVAR and open repair when not suitable) or to immediate open repair
with CT being optional. IMPROVE enrolled patients from 29 vascular cen-
ters in the UK and one in Canada from 2009 to 2013. There were 613
eligible patients (480 men) with a clinical diagnosis of rAAA. Three hundred
sixteen patients were randomized to the endovascular strategy and the diag-
nosis of rAAA was conﬁrmed in 275 (87%), 8 (3%) had repair of a symptom-
atic nonruptured AAA in the same admission, and 33 (10%) had other
discharge diagnoses. Of the patients with ruptured or symptomatic AAA
272 had a CT performed and 174 (64%) were considered anatomically suit-
able for EVAR with local reporting of unfavorable anatomy at the aneurysm
neck the most common reason for lack of suitability for EVAR (75/84 cases).
EVAR was then attempted in 154 patients (four converted to open repair),
open repair was attempted in 112 other patients (84 anatomically unsuitable
for EVAR. There were 28 crossovers who were anatomically suitable for
EVAR, 16 patients died before aneurysm repair, and 1 patient with a symp-
tomatic aneurysm refused repair and was discharged). There were 297 pa-
tients randomized to open repair with the diagnosis of rAAA conﬁrmed in
261 (88%). Fourteen (5%) had repair of a symptomatic intact aneurysm in
the same admission and 22 (7%) had another discharge diagnosis. In this
group EVAR was attempted in 36 (13%) patients and open repair in 220
(80%) patients, and 19 patients died before aneurysm repair. Main outcome
measures were 30-day mortality and 24-hour and in-hospital mortality, costs,
with and time and place of discharge as secondary outcomes. 30-day mortal-
ity was 35.4% in the endovascular strategy group and 37.4% in the open repair
group: odds ratio, 0.92 (95% CI, 0.66-1.28, P¼ .62); odds ratio after adjust-
ment for age, sex, and Hardman index, 0.94 (95% CI, 0.67-1.33). Endovas-
cular strategy may have provided some beneﬁt for women (interaction test,
P ¼ .02), odds ratio, 0.44 (95% CI, 0.22-0.91) versus 1.18 (95% CI, 0.80-
1.75). Thirty-day mortality for patients with conﬁrmed rupture was 36.4%
(100/275) in the endovascular strategy group and 40.6% (106/261) in
the open repair group (P¼ .31). There were more patients in the endovascu-
lar strategy than in the open repair group who were discharged directly to
home (189/201 [94%] v 141/183 [77%]; P < .001). Average 30-day costs
were similar between the groups.
Comment: The study indicates that an endovascular strategy for a rAAA
has similar mortality as open surgical repair of rAAA. It also suggests, however,
that an endovascular strategy may beneﬁt women patients with rAAAA and
may result in a greater ability to discharge patients to home with less time in
the ICU than open surgery for a rAAA. Observational studies previously re-
ported improvedmortality results with endovascular repair for rAAAhave likely
been subject to institutional bias, selection bias and perhaps reporting bias.
Nevertheless, a strategy for repair of rAAA that includes possible endovascular
repair may offer beneﬁts for selected patients in terms of reduced time in the
ICU and a greater ability to discharge home.
